Deschide articolul original într-un tab nou Schimbarea acestei opțiuni se aplică imediat și reîncarcă pagina.
LECTURA
← Înapoi la Urmăritori

What the Fundus

whatthefundus.com/posts_feed
Vizitează site-ul

Cel mai recent articol

Ultima verificare

Urmăritori 0 urmăritori
Articole: 25

  1. Optometrists using frickin laser beams

    (What the Fundus)

    Lighthizer, N., Chen, J., Niyazmand, H., Patel, K., Janzen, J., Xu, P., … Alam, K. (2026).

  2. Paradox of atropine in myopia control

    (What the Fundus)

    Wu Y and Chen Y (2026) Paradox of atropine in myopia control: exploring dose-dependent efficacy, rebound effects, and optimal risk-benefit balance–a perspective.

  3. Yes, eye rubbing is bad (probably)

    (What the Fundus)

    Mavris, N., Lavy, I., Ambrósio Jr., R., & Smadja, D. (2026).

  4. The effect of rhegmatogenous retinal detachment on retinal oxygenation

    (What the Fundus)

    Petri AS, Krarup TG, Traustason S, Hajari JN, Hardarson SH, Kyhnel A, Kiilgaard JF, Stefansson E, de La Cour MD.

  5. When Diabetes and Depression Overlap: What Inflammatory Markers Reveal

    (What the Fundus)

    Association between inflammatory biomarkers and depressive symptoms among diabetes mellitus and diabetic retinopathy: A cross-sectional study Tang S, Li H, Wang Z, Wang B, Li Y, Dai C.

  6. Why does HydraGlyde exist?

    (What the Fundus)

    I have more patients who have problems with using this solution than ones whose comfort is improved by it.

  7. The Cholesterol Code

    (What the Fundus)

    I forgot to post about this, but my friend and colleague Dr.

  8. Diabetic Retinopathy Outcomes and Early Worsening of Diabetic Retinopathy

    (What the Fundus)

    Diabetic Retinopathy Outcomes and Early Worsening of Diabetic Retinopathy in Adolescents and Young Adults With Type 1 Diabetes Following Rapid and Large Glycemic Improvements After Commencing Automated Insulin Delivery Warunyuwong W, et al.

  9. Optic nerve head abnormalities in primary open-angle glaucoma and their associations with axial length

    (What the Fundus)

    Saito, H., Wang, W., Akiyama, K. et al.

  10. Changing times

    (What the Fundus)

    I was at a meeting last night where the lecturer discussed how many OCTs he ordered monthly.

  11. Hyperbaric oxygen therapy for CRAO

    (What the Fundus)

    Werling D, Rák T, Kanász G, Göbl A, Borbély G, Csutak A.

  12. Do not use petroleum-based ointments with the PRESERFLO Microshunt

    (What the Fundus)

    Tomita, R., Inooka, T., Kajita, T. et al.

  13. Valeda

    (What the Fundus)

    I heard about Valeda (LumiThera, recently purchased by Alcon) recently from a patient.

  14. Lacrifill

    (What the Fundus)

    Packer, Mark MD; Lindstrom, Richard MD; Thompson, Vance MD; Parekh, Jai G.

  15. Alternate ocular parameters contribute to soft contact lens discomfort

    (What the Fundus)

    Viñuela JR, Wolffsohn JS, Consejo A, van der Worp E, Piñero DP.

  16. Electroconductivity of Saliva as a Diagnostic Tool for Dry Eye Disease: A Case-Control Study

    (What the Fundus)

    Yung-Kang Chen, Chien-Hsiung Lai, Wei-Chi Wu, Chi-Hua Wang, Ko-Ming Lin, Nan-Ni Chen, Jen-Tsung Yang, Pei-Lun Wu; Electroconductivity of Saliva as a Diagnostic Tool for Dry Eye Disease: A Case-Control Study.

  17. Sex Differences in Inflammatory Plasma Proteins in Patients With Diabetic Retinopathy

    (What the Fundus)

    Xinyi Chen, Alythia Vo, Wendy Yang, Joshua Wu, Daphne Yang, Matthew Huh, Ricardo Lamy, Jeremy D.

  18. Novel therapy for Macular Telangiectasia Type 2

    (What the Fundus)

    Emily Y.

  19. Gut microbiota in gestational diabetes

    (What the Fundus)

    Hu, Linhua BSNa; Liu, Hongli BSNb; Liang, Fengbing BSNc; Du, Zhi MScd; Jiang, Shudan BSNc; Chen, Guoxia BSNa; Fang, Xiaoting BSNa; Bi, Lixia BSNa,*.

  20. Finding a pathway of the cause of damage to the retina in diabetes

    (What the Fundus)

    Wang, L.

  21. Endocannabinoid use in ocular pathology

    (What the Fundus)

    Charytoniuk, T., Półjanowski, S., Michalak, M., Kaźmierczak, K., & Kałużny, B. (2025).

  22. Using OCT biomarkers to aid in optic neuritis diagnosis in multiple sclerosis

    (What the Fundus)

    Safwat, H.

  23. Genetic testing in eye care

    (What the Fundus)

    Kellner, U., Kellner, S., Weinitz, S., & Farmand, G. (2025).

  24. Current treatments of Leber’s hereditary optic neuropathy

    (What the Fundus)

    Leber’s hereditary optic neuropathy (LHON) is the most common mitochondrial disease, characterized by the painless loss of central vision.

  25. Ocular trauma in sports

    (What the Fundus)

    Chaudhary, A., Carr, E.